Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Amortizatization of Intangibles (2019 - 2025)

Merit Medical Systems' Amortizatization of Intangibles history spans 7 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 6.44% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $11.5 million, down 4.51%, while the annual FY2025 figure was $11.5 million, 4.51% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $2.8 million at Merit Medical Systems, down from $2.9 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.3 million in Q2 2023 and bottomed at $2.5 million in Q2 2022.
  • The 5-year median for Amortizatization of Intangibles is $2.8 million (2021), against an average of $2.8 million.
  • The largest annual shift saw Amortizatization of Intangibles dropped 15.83% in 2022 before it grew 29.01% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $2.8 million in 2021, then dropped by 7.27% to $2.6 million in 2022, then grew by 4.31% to $2.7 million in 2023, then increased by 10.95% to $3.0 million in 2024, then decreased by 6.44% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Amortizatization of Intangibles are $2.8 million (Q4 2025), $2.9 million (Q3 2025), and $2.8 million (Q2 2025).